IA
ADMA icon

IFP Advisors’s ADMA Biologics ADMA Stock Holding History

IFP Advisors’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-174
Closed -$1.57K – 5127
2026
Q1 		$1.57K Hold
174
– – ﹤0.01% 4049
2025
Q4 		$3.17K Buy
174
+24
+16% +$404 ﹤0.01% 3650
2025
Q3 		$2.2K Sell
150
-66
-31% -$1.13K ﹤0.01% 3653
2025
Q2 		$3.93K Buy
216
+115
+114% +$2.35K ﹤0.01% 3543
2025
Q1 		$2K Sell
101
-17
-14% -$294 ﹤0.01% 3148
2024
Q4 		$2.02K Buy
+118
New +$2.22K ﹤0.01% 3104
2023
Q4 		– Sell
-1,150
Closed -$4.12K – 3039
2023
Q3 		$4.12K Buy
+1,150
New +$4.43K ﹤0.01% 2589

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

IFP Advisors's ADMA Position: Q2 2026 in Review

IFP Advisors sold out of ADMA Biologics (ADMA) in Q2 2026, closing a stake of 174 shares — an estimated $1.57K sold.

IFP Advisors first reported a position in ADMA in Q3 2023 and held it in 7 quarters. The position peaked at $4.12K in Q3 2023. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • IFP Advisors reported no remaining ADMA Biologics position as of Q2 2026 after selling out during the quarter.
  • IFP Advisors sold 174 ADMA Biologics shares in Q2 2026, an estimated $1.57K.
  • IFP Advisors first reported a position in ADMA Biologics in Q3 2023 and held it in 7 quarters.
  • IFP Advisors's ADMA Biologics position peaked at $4.12K in Q3 2023.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.